This is a $1,878,955.92 fixed-price level of effort contract awarded by the Department of the Air Force Air Mobility Command to Beyond Barriers Therapeutics, Inc., a for-profit organization, for the development of an intranasal treatment for mild traumatic brain injury. The contract was awarded on July 25, 2023 and has a completion date of July 24, 2025.
The original solicitation was a Broad Agency Announcement (BAA) issued by the Department of the Army Medical Command from August 1, 2018 through July 31, 2023 to support basic and applied research in areas that can inform both military and civilian medical practice. This contract award falls under that BAA, which did not have a set-aside designation.
Generated 4/16/24, 5:35 PM